Sildenafil on Valvular Heart Disease & Residual Pulmonary Hypertension at ESC 2017

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

Sildenafil on Valvular Heart Disease & Residual Pulmonary Hypertension at ESC 2017

Published: 25 Sep 2017

Views:
277
Likes:
0

Average (ratings)

No ratings

Your rating

This interview with Javier Bermejo from Hospital General Universitario Gregorio Marañon, Madrid, ES discusses the Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension (SIOVAC) at ESC 2017.

Filmed by Radcliffe Cardiology on-site at EASD 2017.